Home › Trial NCT06402201
First in Human Study of CDR404 in HLA-A*02:01 Participants With MAGE-A4 Expressing Solid Tumors
- Trial IDNCT06402201
- StatusRecruiting
- PhasePhase 1
- Study typeInterventional
- SponsorCDR-Life AG
- Enrollment42
- Start date2024-05-24
- ConditionsSelect Advanced Solid Tumors
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.